sk&f 86002 has been researched along with Hematologic Malignancies in 1 studies
6-(4-fluorophenyl)-2,3-dihydro-5-(4-pyridinyl)imidazo(2,1-b)thiazole: inhibits p38 MAP kinase
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, L | 1 |
| Weetall, M | 1 |
| Trotta, C | 1 |
| Cintron, K | 1 |
| Ma, J | 1 |
| Kim, MJ | 1 |
| Furia, B | 1 |
| Romfo, C | 1 |
| Graci, JD | 1 |
| Li, W | 1 |
| Du, J | 1 |
| Sheedy, J | 1 |
| Hedrick, J | 1 |
| Risher, N | 1 |
| Yeh, S | 1 |
| Qi, H | 1 |
| Arasu, T | 1 |
| Hwang, S | 1 |
| Lennox, W | 1 |
| Kong, R | 1 |
| Petruska, J | 1 |
| Moon, YC | 1 |
| Babiak, J | 1 |
| Davis, TW | 1 |
| Jacobson, A | 1 |
| Almstead, NG | 1 |
| Branstrom, A | 1 |
| Colacino, JM | 1 |
| Peltz, SW | 1 |
1 other study available for sk&f 86002 and Hematologic Malignancies
| Article | Year |
|---|---|
Targeting of Hematologic Malignancies with PTC299, A Novel Potent Inhibitor of Dihydroorotate Dehydrogenase with Favorable Pharmaceutical Properties.
Topics: Animals; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dihydroorotate Dehydrogenase; Hematolo | 2019 |